Capstone Therapeutics Expands Stock Purchase Agreement with Equity Line Investor, Increases Purchase Limit to $3 Million

Reuters
06-27
Capstone <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Expands Stock Purchase Agreement with Equity Line Investor, Increases Purchase Limit to $3 Million

Capstone Therapeutics Corporation has entered into a significant stock purchase agreement with an accredited investor, involving the potential sale of up to $20 million in common stock. Under the terms of this agreement, Capstone has the option to sell shares to the investor, priced at 97% of the lowest daily volume-weighted average price over a three-day period. Additionally, a recent amendment to this agreement has increased the limits on the volume and dollar amount of shares that can be purchased in a single transaction. This amendment allows for a maximum purchase of up to 40% of the trading volume or $3 million, whichever is lower, enhancing Capstone's financial flexibility and capital-raising options.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capstone Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-058624), on June 27, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10